Walleye Capital LLC Morphic Holding, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$19.95 - $31.0 $3.19 Million - $4.95 Million	-159,832 Reduced 93.69%	10,767 $310,000
Q3 2023 Nov 14, 2023	BUY	$21.33 - $59.42 $3.64 Million - $10.1 Million	170,599 New	170,599 $3.91 Million
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $256,722 - $368,405	-7,082 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$43.27 - $65.72 $306,438 - $465,429	7,082 New	7,082 $335,000
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $194,961 - $280,756	-4,320 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $128,606 - $366,552	4,320 New	4,320 $273,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.